Clinical Trial Update: Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating temperature-sensitive liposomal doxorubicin with hyperthermia in women with locally recurrent breast cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ThermoDox (doxorubicin liposome)

Snippet

Sponsor: Duke University | Conditions: Breast Cancer | Phase 1 | Status: TERMINATED